T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Medifast
MED
$128M
| $252K | ﹤0.01% |
18,405
+3,612
| +24% | +$50.5K |
|
2677
American Battery Technology Co
ABAT
$342M
| $251K | ﹤0.01% |
51,586
+10,576
| +26% | +$27.6K |
|
2678
Preformed Line Products
PLPC
$2.19B
| $251K | ﹤0.01% |
+1,277
| New | +$224K |
|
2679
Quad
QUAD
$506M
| $250K | ﹤0.01% |
39,794
| – | – |
|
2680
Mastech Digital
MHH
$95.3M
| $249K | ﹤0.01% |
32,598
| – | – |
|
|
NB
2681
NioCorp Developments
NB
$745M
| $249K | ﹤0.01% |
37,245
+11,141
| +43% | +$47K |
|
2682
Rayonier Advanced Materials
RYAM
$570M
| $249K | ﹤0.01% |
34,407
+5,027
| +17% | +$25.9K |
|
|
JBS
2683
JBS N.V.
JBS
$43.8B
| $246K | ﹤0.01% |
+16,429
| New | +$240K |
|
|
GDEN
2684
DELISTED
Golden Entertainment
GDEN
| $245K | ﹤0.01% |
10,349
+492
| +5% | +$13.1K |
|
|
MOFG
2685
DELISTED
MidWestOne Financial Group
MOFG
| $245K | ﹤0.01% |
8,628
-1,631
| -16% | -$47.6K |
|
2686
Real Brokerage
REAX
$523M
| $245K | ﹤0.01% |
58,427
+4,165
| +8% | +$18.8K |
|
2687
Bar Harbor Bankshares
BHB
$681M
| $244K | ﹤0.01% |
7,999
+860
| +12% | +$26.9K |
|
|
MCHB
2688
Mechanics Bancorp
MCHB
$3.79B
| $244K | ﹤0.01% |
18,284
+743
| +4% | +$9.88K |
|
2689
Inogen
INGN
$154M
| $244K | ﹤0.01% |
29,828
+368
| +1% | +$2.75K |
|
|
KALV
2690
DELISTED
KalVista Pharmaceuticals
KALV
| $244K | ﹤0.01% |
19,980
+2,116
| +12% | +$29.2K |
|
2691
Tiptree Inc
TIPT
$677M
| $244K | ﹤0.01% |
12,724
| – | – |
|
2692
Park-Ohio Holdings
PKOH
$718M
| $243K | ﹤0.01% |
11,394
+620
| +6% | +$11.9K |
|
2693
DMC Global
BOOM
$153M
| $242K | ﹤0.01% |
28,627
| – | – |
|
2694
Savara
SVRA
$1.08B
| $241K | ﹤0.01% |
67,420
+11,753
| +21% | +$34.8K |
|
2695
Peoples Financial Services
PFIS
$717M
| $240K | ﹤0.01% |
4,936
+524
| +12% | +$26.8K |
|
2696
ACNB Corp
ACNB
$660M
| $239K | ﹤0.01% |
5,420
+268
| +5% | +$11.8K |
|
2697
Corvus Pharmaceuticals
CRVS
$1.27B
| $239K | ﹤0.01% |
32,409
+6,110
| +23% | +$31.3K |
|
2698
GrafTech
EAF
$203M
| $239K | ﹤0.01% |
18,638
| – | – |
|
2699
Redwire
RDW
$3.3B
| $239K | ﹤0.01% |
26,538
+9,740
| +58% | +$114K |
|
2700
Alto Neuroscience
ANRO
$1.26B
| $239K | ﹤0.01% |
59,428
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.